Cancer
Sanofi, Evotec and Apeiron partner on immuno-oncology
August 10, 2015Research and Development, Sales and Marketing Apeiron, Cancer, Evotec, Sanofi, immuno-oncology, immunotherapy, tumours
Sanofi is partnering with biotech companies Evotec and Apeiron to develop new cancer immuno-oncology therapies.The companies say the potential new …
MedImmune and Mirati to partner on lung cancer combo
August 6, 2015Research and Development AstraZeneca, Cancer, MedImmune, Mirati, Mirati Therapeutics, NSCLC, durvalumab, immuno-oncology, immunotherapy, lung cancer, mocetinostat
MedImmune is entering into an exclusive clinical trial collaboration with US-based Mirati Therapeutics to test a novel immuno-oncology combination in …
AstraZeneca buys rights to Heptares experimental cancer treatment
August 6, 2015Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, HTL-1071, immuno-oncology
AstraZeneca has entered into a licensing agreement with Heptares for the global rights to the experimental cancer treatment HTL-1071. The …
Sanofi and Regeneron in immuno-oncology push
July 28, 2015Manufacturing and Production, Research and Development Cancer, PD-1 inhibitors, Regeneron, Sanofi, collaboration, immuno-oncology, pd-1
Pharma giants Sanofi and Regeneron are extending the partnership that brought new heart drug Praluent to the market, with a …
Cancer Drugs Fund assessment to be handed over to NICE
July 22, 2015Medical Communications, Research and Development CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, NHSE, NICE, cost effectiveness, cost-effectiveness
NICE will oversee the evaluation of Cancer Drugs Fund treatments in future, under new plans due for consultation by NHS …
BMS’ Opdivo accepted to UK early access scheme
June 30, 2015Sales and Marketing BMS, Cancer, NSCLC, eams, keytruda, opdivo
Bristol-Myers Squibb has scored another first with its new-generation oncology therapy Opdivo, which has become the first lung cancer drug …
NICE reworks cancer guidance for GPs
June 23, 2015Sales and Marketing Cancer, GPs, NICE, UK, baker, research
The National Institute for Health and Care Excellence says thousands of lives will be saved each year if GPs and …
Lilly and AstraZeneca collaborate on cancer trials
May 29, 2015Research and Development AstraZeneca, Cancer, Eli Lilly, MedImmune, immuno-oncology, immunotherapy, lilly, oncology, phase I
AstraZeneca and Eli Lilly are teaming up to run a clinical trial of two of the companies’ anti-cancer drugs. The …
Amgen cold sore virus drug shows ‘significant’ cancer benefit
May 27, 2015Research and Development, Sales and Marketing Amgen, Cancer, cold sore, t-vec
Amgen is pinning its hopes on investigational viral treatment T-VEC following promising results from a ‘landmark’ skin cancer study. People …
Sanofi prostate cancer drug to remain on CDF
May 26, 2015Sales and Marketing CDF, Cancer, NHS, Sanofi, list, prostate
Sanofi has reached an agreement with NHS England to reinstate its prostate cancer drug Jevtana on the Cancer Drugs Fund. …
Industry awaits key immunotherapy results at ASCO
May 20, 2015Research and Development, Sales and Marketing ASCO, Cancer, oncology, pharma
This year’s American Society of Clinical Oncology (ASCO) conference has a strong focus on immunotherapy, as pharma ramps up its …
Baxter buys cancer portfolio for $900 million
May 13, 2015Research and Development, Sales and Marketing Cancer, Oncaspar, Sigma-Tau Finanziaria, baxter, oncology
Baxter is buying leukaemia treatment Oncaspar from Italian firm Sigma-Tau Finanziaria for $900 million as the US firm looks to …
Takeda announces new cancer collaboration
May 11, 2015Research and Development, Sales and Marketing Cancer, Europe, Takeda, mental health, ncc
Takeda will be teaming up with Japan’s National Cancer Center (NCC) to develop new cancer drugs. The two organisations have …
Worldwide cancer spending tops $100 billion
May 5, 2015Research and Development, Sales and Marketing Cancer, IMS Health, keytruda, oncology
Over $100 billion was spent on cancer medicines across the world last year as a new generation of drugs begins …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
